Patient‐Derived iPSC Neuronal Models Reveal Alzheimer’s Disease‐Associated Pathology and Provide a Platform for Drug Discovery

Our iPSC-based AD Panel provides a robust, human-relevant model for studying sporadic AD pathophysiology. The ability to recapitulate key AD hallmarks in patient-derived neurons supports their use in target validation, biomarker identification, and personalized drug screening. This scalable model facilitates therapeutic discovery and precision medicine approaches in AD research.